Literature DB >> 7975198

Altered endothelium-dependent alpha-adrenergic vascular reactivity following exposure to Pasteurella haemolytica antigens.

L B Weekley1, P Eyre.   

Abstract

Rats were injected with sterile saline (controls), 10(5) cfu of Pasteurella haemolytica (biotype A) obtained from a commercial vaccine, or a commercial Pasteurella leukotoxoid vaccine. Three days after vaccination, the animals were killed and the thoracic aorta was removed. In some experiments the vascular endothelium was mechanically removed. Each isolated aorta was placed in a tissue bath and the biophysical responses to methoxamine (alpha-1 agonist) were determined. In separate experiments the endothelial surface was examined by scanning electron microscopy. In endothelium-intact vessels both vaccines appeared to enhance the contractile response to methoxamine. On the other hand, in endothelial-denuded vessels, the methoxamine-mediated contractile response was enhanced in the P. haemolytica-treated group but not in animals vaccinated with leukotoxoid. Furthermore, scanning electron microscopy revealed deposition of a fibrin-like material on the endothelial surface of vaccinated animals. These results suggest that exposure to vaccine-derived P. haemolytica antigens alters the morphology and adrenergic responsiveness of vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975198     DOI: 10.1007/BF01839232

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  17 in total

1.  Alpha-adrenergic hyper-responsiveness in asthma.

Authors:  W R Henderson; J H Shelhamer; D B Reingold; L J Smith; R Evans; M Kaliner
Journal:  N Engl J Med       Date:  1979-03-22       Impact factor: 91.245

2.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

3.  Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells.

Authors:  T Nakane; T Szentendrei; L Stern; M Virmani; J Seely; G Kunos
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

4.  Time course of recovery of beta- and alpha 1-adrenoceptors in experimental asthma.

Authors:  J Shindoh; S Sugiyama; K Hayashi; K Takagi; T Satake; T Ozawa
Journal:  Clin Exp Pharmacol Physiol       Date:  1990-07       Impact factor: 2.557

5.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

6.  Morphological and functional disturbances in pulmonary vascular endothelium following exposure of sheep to an "avirulent" strain of Pasteurella haemolytica.

Authors:  L B Weekley; P Eyre; H P Veit; N Sriranganathan
Journal:  J Comp Pathol       Date:  1993-01       Impact factor: 1.311

7.  Vaccination with live Pasteurella haemolytica alters vascular adrenergic reactivity.

Authors:  L B Weekley; P Eyre
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1993-03

8.  Adrenergic stimulation of vascular prostacyclin: role of alpha 1-receptors in smooth muscle cells.

Authors:  J M Boeynaems; D Demolle; N Galand
Journal:  Eur J Pharmacol       Date:  1987-12-01       Impact factor: 4.432

9.  A field trial to evaluate the efficacy of a commercial Pasteurella haemolytica bacterial extract in preventing bovine respiratory disease.

Authors:  B Thorlakson; W Martin; D Peters
Journal:  Can Vet J       Date:  1990-08       Impact factor: 1.008

10.  Interactions of cold stress and Pasteurella haemolytica in the pathogenesis of pneumonic pasteurellosis in calves: method of induction and hematologic and pathologic changes.

Authors:  R F Slocombe; F J Derksen; N E Robinson; A Trapp; A Gupta; J P Newman
Journal:  Am J Vet Res       Date:  1984-09       Impact factor: 1.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.